Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companies.
Small biopharma companies often need to partner with larger firms to achieve their goals. Here, Diane Seimetz and Jörg Schneider discuss how due diligence smooths the path to collaboration.
Cell and gene therapies have significantly progressed and as a result, manufacturing process consistency, GMP standards and more must now meet more formal requirements. Elena Meurer, Principal Consultant and CMC expert at Biopharma Excellence, explains.